Overexpression of the Notch3 receptor and its ligand Jagged1 in human clinically non-functioning pituitary adenomas
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of the Notch3 receptor and its ligand Jagged1 in human clinically non-functioning pituitary adenomas
Authors
Keywords
-
Journal
Oncology Letters
Volume 5, Issue 3, Pages 845-851
Publisher
Spandidos Publications
Online
2013-01-07
DOI
10.3892/ol.2013.1113
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Jagged1 expression regulated by Notch3 and Wnt/β-catenin signaling pathways in ovarian cancer
- (2015) Oncotarget
- Ligand-driven activation of the Notch pathway in T-all and solid tumors: Why Not(ch)?
- (2011) Stefano Indraccolo et al. CELL CYCLE
- Targeting the Notch Ligand Jagged1 in Both Tumor Cells and Stroma in Ovarian Cancer
- (2011) A. D. Steg et al. CLINICAL CANCER RESEARCH
- Persistent expression of activated Notch inhibits corticotrope and melanotrope differentiation and results in dysfunction of the HPA axis
- (2011) Leah B. Goldberg et al. DEVELOPMENTAL BIOLOGY
- Overexpression of the Notch3 receptor in non-functioning pituitary tumours
- (2011) Zengli Miao et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Notch3 signalling promotes tumour growth in colorectal cancer
- (2011) Valentina Serafin et al. JOURNAL OF PATHOLOGY
- MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma
- (2011) V Ramakrishnan et al. LEUKEMIA
- Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells
- (2011) M Masiero et al. LEUKEMIA
- Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer
- (2011) M Kondratyev et al. ONCOGENE
- NOTCH1 and NOTCH3 Coordinate Esophageal Squamous Differentiation Through a CSL-Dependent Transcriptional Network
- (2010) Shinya Ohashi et al. GASTROENTEROLOGY
- Non-functioning pituitary adenomas
- (2009) Yona Greenman et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Down-regulation of the Notch pathway mediated by a γ-secretase inhibitor induces anti-tumour effects in mouse models of T-cell leukaemia
- (2009) J Tammam et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Notch Target GeneHes1Regulates Cell Cycle Inhibitor Expression in the Developing Pituitary
- (2009) Pamela Monahan et al. ENDOCRINOLOGY
- Notch3 cooperates with the EGFR pathway to modulate apoptosis through the induction of bim
- (2009) J Konishi et al. ONCOGENE
- Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer
- (2009) V. Rodilla et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NOTCH3 Signaling Pathway Plays Crucial Roles in the Proliferation of ErbB2-Negative Human Breast Cancer Cells
- (2008) N. Yamaguchi et al. CANCER RESEARCH
- Jagged-1 and Notch3 Juxtacrine Loop Regulates Ovarian Tumor Growth and Adhesion
- (2008) J.-H. Choi et al. CANCER RESEARCH
- Notch signaling regulates endocrine cell specification in the zebrafish anterior pituitary
- (2008) Sunit Dutta et al. DEVELOPMENTAL BIOLOGY
- Medical therapy for clinically non-functioning pituitary adenomas
- (2008) A. Colao et al. ENDOCRINE-RELATED CANCER
- Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RT-qPCR, and proteomic analyses
- (2008) Chheng-Orn Evans et al. Pituitary
- Medical therapy of pituitary adenomas: Effects on tumor shrinkage
- (2008) Annamaria Colao et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started